{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:36:46Z","timestamp":1784083006057,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.cancergen.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T02:40:41Z","timestamp":1517798441000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia"],"prefix":"10.1016","volume":"222-223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8367-0090","authenticated-orcid":false,"given":"Marcela","family":"Cavalcante de Andrade Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2931-8605","authenticated-orcid":false,"given":"Ana Cristina Victorino","family":"Krepischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Domenici","family":"Kulikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin Aline","family":"Zanardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Nardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Medeiros","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Souza","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nair Hideki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-0579","authenticated-orcid":false,"given":"Elvira Deolinda Rodrigues Pereira","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.cancergen.2018.01.002_bib0001","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.cancergen.2018.01.002_bib0002","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","author":"Churpek","year":"2016","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.cancergen.2018.01.002_bib0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevOncog.v16.i1-2.80","article-title":"RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making","volume":"16","author":"Mangan","year":"2011","journal-title":"Crit Rev Oncog"},{"issue":"8","key":"10.1016\/j.cancergen.2018.01.002_bib0004","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ejhg.2008.89","article-title":"Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions","volume":"16","author":"B\u00e9ri-Dexheimer","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.cancergen.2018.01.002_bib0005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood-2014-06-585513","article-title":"Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia","volume":"125","author":"Antony-Debre","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cancergen.2018.01.002_bib0006","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/leu.2009.87","article-title":"A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation","volume":"23","author":"Ripperger","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cancergen.2018.01.002_bib0007","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1111\/hae.13169","article-title":"Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation","volume":"23","author":"Badin","year":"2017","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.cancergen.2018.01.002_bib0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jth.12550","article-title":"Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets","volume":"12","author":"Glembotsky","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1016\/j.cancergen.2018.01.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cancergen.2018.01.002_bib0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/annonc\/mdw066","article-title":"Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan","volume":"27","author":"Yoshimi","year":"2016","journal-title":"Ann Oncol"},{"issue":"22","key":"10.1016\/j.cancergen.2018.01.002_bib0011","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1182\/blood-2008-07-168260","article-title":"High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder","volume":"113","author":"Preudhomme","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cancergen.2018.01.002_bib0012","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cancergen.2018.01.002_bib0013","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debr\u00e9","year":"2016","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cancergen.2018.01.002_bib0014","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2017.167726","article-title":"Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation","volume":"102","author":"Kanagal-Shamanna","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cancergen.2018.01.002_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.cancergen.2018.01.002_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.leukres.2009.06.030","article-title":"Constitutional RUNX1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 ITSN1 as a candidate gene in mental retardation","volume":"34","author":"van der Crabben","year":"2010","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.cancergen.2018.01.002_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminhematol.2017.04.006","article-title":"RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)","volume":"54","author":"Schlegelberger","year":"2017","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.cancergen.2018.01.002_bib0018","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/leu.2009.210","article-title":"Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD\/AML syndrome","volume":"24","author":"Jongmans","year":"2010","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.cancergen.2018.01.002_bib0019","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/leu.2012.79","article-title":"Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD\/AML pedigrees","volume":"26","author":"Buijs","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cancergen.2018.01.002_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.cancergen.2018.01.002_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149119","article-title":"Transcriptional auto-regulation of RUNX1 P1 promoter","volume":"11","author":"Martinez","year":"2016","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.cancergen.2018.01.002_bib0022","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","article-title":"RUNX transcription factors in the development and function of the definitive hematopoietic system","volume":"129","author":"Bruijn","year":"2017","journal-title":"Blood"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:57Z","timestamp":1761896517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217302879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":22,"alternative-id":["S2210776217302879"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.01.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}